Index | S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care |
Investment focus | Equity, World, Health Care, Social/Environmental |
Fund size | GBP - m |
Total expense ratio | 0.18% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Yes |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 11.81% |
Inception/ Listing Date | 12 April 2023 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Invesco |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | BNY Mellon Fund Services (Ireland) Designated Activity Company |
Investment Advisor | Invesco Capital Management LLC |
Custodian Bank | BNY Mellon Trust Company (Ireland) Limited |
Revision Company | PricewaterhouseCoopers |
Fiscal Year End | 31 December |
Swiss representative | BNP PARIBAS SECURITIES SERVICES, Paris, succursale de Zurich |
Swiss paying agent | BNP PARIBAS SECURITIES SERVICES, Paris, succursale de Zurich |
Germany | Unknown |
Switzerland | Unknown |
Austria | Unknown |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
UnitedHealth Group | 9.51% |
Eli Lilly & Co | 8.80% |
AbbVie | 7.32% |
Novo Nordisk | 5.73% |
Merck & Co | 4.77% |
AstraZeneca | 3.96% |
Thermo Fisher Scientific | 3.91% |
Novartis | 3.63% |
Amgen | 3.20% |
Roche Holding | 2.99% |
United States | 68.61% |
Switzerland | 6.98% |
United Kingdom | 4.42% |
Japan | 4.39% |
Other | 15.60% |
Health Care | 93.84% |
Consumer Discretionary | 0.25% |
Other | 5.92% |
YTD | +7.05% |
1 month | +2.84% |
3 months | +1.95% |
6 months | +11.61% |
1 year | +9.53% |
3 years | - |
5 years | - |
Since inception (MAX) | +8.28% |
2023 | - |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | 11.81% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 0.81 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -8.35% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -10.43% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | WH2E | - - | - - | - |
Borsa Italiana | EUR | WDHE | WDHE IM WHCEINE | WDHE.MI I2PZINAV.DE | Societe Generale |
London Stock Exchange | GBX | WHCG | WHCG LN WHCEINS | WHCG.L I2P0INAV.DE | Societe Generale |
London Stock Exchange | USD | WHCE | WHCE LN WHCEIN | WHCE.L I2P1INAV.DE | Societe Generale |
SIX Swiss Exchange | USD | WHCE | WHCE SW WHCEIN | WHCE.S I2P1INAV.DE | Societe Generale |
XETRA | EUR | WH2E | WH2E GY WHCEINE | WH2E.DE I2PZINAV.DE | Societe Generale |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 995 | 0.40% p.a. | Accumulating | Sampling |
iShares Ageing Population UCITS ETF | 442 | 0.40% p.a. | Accumulating | Sampling |
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 140 | 0.35% p.a. | Accumulating | Full replication |
iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc) | 89 | 0.18% p.a. | Accumulating | Sampling |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 6 | 0.35% p.a. | Accumulating | Full replication |